Moreover, anti-IL-17A could protect the lungs in lipopolysaccharide (LPS)-induced acute lung injury and improve survival in polymicrobial sepsis induced by cecal ligation and puncture (CLP) (13–15). This evidence concerns the gene IL17A and Sepsis.